Abemaciclib (Standard)
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Abemaciclib (Standard)
Description:
Abemaciclib (Standard) is the analytical standard of Abemaciclib. This product is intended for research and analytical applications. Abemaciclib (LY2835219) is a selective CDK4/6 inhibitor with IC50 values of 2 nM and 10 nM for CDK4 and CDK6, respectively.Product Name Alternative:
LY2835219 (Standard)UNSPSC:
12352005Hazard Statement:
H360, H373, H410Target:
CDK; Reference StandardsType:
Reference StandardsRelated Pathways:
Cell Cycle/DNA Damage; OthersApplications:
Cancer-Kinase/proteaseField of Research:
CancerAssay Protocol:
https://www.medchemexpress.com/abemaciclib-standard.htmlPurity:
99.94Smiles:
CC1=NC2=C(F)C=C(C3=NC(NC4=NC=C(CN5CCN(CC)CC5)C=C4)=NC=C3F)C=C2N1C(C)CMolecular Formula:
C27H32F2N8Molecular Weight:
506.59Precautions:
H360, H373, H410References & Citations:
[1]Ku BM, et al. The CDK4/6 inhibitor LY2835219 has potent activity in combination with mTOR inhibitor in head and neck squamous cell carcinoma. Oncotarget.?2016 Mar 22;7 (12) :14803-13.|[2]Yadav V, et al. The CDK4/6 inhibitor LY2835219 overcomes PLX4032 resistance resulting from MAPK reactivation and cyclin D1 upregulation. Mol Cancer Ther. 2014 Oct;13 (10) :2253-63.|[3]Gelbert LM, et al. Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with NSC 613327. Invest New Drugs. 2014 Oct;32 (5) :825-37.Shipping Conditions:
Blue IceStorage Conditions:
4°C, sealed storage, away from light and moistureScientific Category:
Reference StandardsCAS Number:
[1231929-97-7]
